Human Histone acetyltransferase MYST3 peptide (ab41910)

Overview

Description

  • NatureSynthetic
  • Amino Acid Sequence
    • SpeciesHuman

Associated products

Specifications

Our Abpromise guarantee covers the use of ab41910 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Blocking - Blocking peptide for Anti-Histone acetyltransferase MYST3 antibody (ab41718)

  • FormLiquid
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

    Preservative: 0.02% Sodium Azide
    Constituents: 0.1% BSA, PBS, pH 7.2

General Info

  • Alternative names
    • HAT 3
    • Histone acetyltransferase MYST3
    • Monocytic leukemia zinc finger protein
    • MOZ
    • MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3
    • MYST histone acetyltransferase (monocytic leukemia) 3
    • MYST protein 3
    • MYST-3
    • MYST3
    • MYST3_HUMAN
    • OTTHUMP00000197392
    • OTTHUMP00000197394
    • OTTHUMP00000225722
    • Runt related transcription factor binding protein 2
    • Runt-related transcription factor-binding protein 2
    • RUNXBP2
    • SAS2
    • SAS2 and TIP60 protein 3
    • TIP60 protein 3
    • YBF2/SAS3
    • ZC2HC6A
    • Zinc finger protein 220
    • ZNF220
    see all
  • FunctionHistone acetyltransferase that acetylates lysine residues in histone H3 and histone H4 (in vitro). Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity. May act as a transcriptional coactivator for RUNX1 and RUNX2.
  • Involvement in diseaseNote=Chromosomal aberrations involving MYST3 may be a cause of acute myeloid leukemias. Translocation t(8;16)(p11;p13) with CREBBP; translocation t(8;22)(p11;q13) with EP300. MYST3-CREBBP may induce leukemia by inhibiting RUNX1-mediated transcription. Inversion inv(8)(p11;q13) generates the MYST3-NCOA2 oncogene, which consists of the N-terminus part of MYST3/MOZ and the C-terminus part of NCOA2/TIF2. MYST3-NCOA2 binds to CREBBP and disrupts its function in transcription activation.
    Note=A chromosomal aberration involving MYST3 is a cause of therapy-related myelodysplastic syndrome. Translocation t(2;8)(p23;p11.2) with ASXL2 generates a MYST3-ASXL2 fusion protein.
  • Sequence similaritiesBelongs to the MYST (SAS/MOZ) family.
    Contains 1 C2HC-type zinc finger.
    Contains 1 H15 (linker histone H1/H5 globular) domain.
    Contains 2 PHD-type zinc fingers.
  • DomainThe N-terminus is involved in transcriptional activation while the C-terminus is involved in transcriptional repression.
  • Post-translational
    modifications
    Autoacetylated.
    Phosphorylated upon DNA damage, probably by ATM or ATR.
  • Cellular localizationNucleus. Partially concentrated in subnuclear foci distinct from PML bodies, and excluded from the nucleoli.
  • Information by UniProt

References for Human Histone acetyltransferase MYST3 peptide (ab41910)

ab41910 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab41910.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"